Skip to main content
SpringerLink
Log in

Rebleeding, ischaemia and hydrocephalus following anti-fibrinolytic treatment for ruptured cerebral aneurysms: A retrospective clinical study

  • Clinical Articles
  • Published:
Acta Neurochirurgica Aims and scope Submit manuscript

Summary

350 patients with subarachnoid haemorrhage from aneurysmal rupture—admitted in the years 1966–1983—were selected for a retrospective controlled study on the efficacy of antifibrinolytic therapy (AFT). Patients treated with antifibrinolytics were divided into two groups, according to the day of hospital admission and onset of therapy, respectively between 0 and 3 days (SG 1) and between 4 and 7 days from SAH (SG2); treated patients (260 cases) received i.v. tranexamic acid (6gr/day) for at least two weeks. Patients admitted before 1974, not receiving antifibrinolytics (90 cases), were selected as controls and divided into two groups (CG 1 and CG 2), according to the day of admission. In the first study group (admission 0–3 days) the rebleeding rate within 2 weeks was 9% versus 23% in controls (p<0.01). The incidence of rebleeding within 3 and 4 weeks was also significantly lower (p<0.05) than in controls. No significant difference was observed in the rebleeding rate in treated and untreated patients with late admission (4–7 days). Mortality from rebleeding was 16% in the first study group versus 17% in controls; in the second study group the figure was 6% versus 8% in controls. Seventy-five cases of ischaemic disorders (29%) were registered in treated patients versus 13 cases in controls (14%; p < 0.01). Thirty-seven patients receiving AFT (14%) developed significant ventricular dilatation requiring shunt insertion, versus one patient in the control groups (1%; p<0.001). Final outcome was similar in the 4 groups. In conclusion—according to our data—AFT modifies the behaviour of rebleeding and the patients' course, although it does not modify the outcome after SAH. Clinical use of antifibrinolytic therapy appears still justified in those patients who cannot be operated on in the acute stage after SAH, provided that an associated anti-ischaemic therapy is undertaken.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Adams HP (1982) Current status of antifibrinolytic therapy for treatment of patients with aneurysmal subarachnoid haemorrhage. Stroke 13: 256–259

    PubMed  Google Scholar 

  2. Adams HP, Kassell NF, Torner JC, Nibbelink DW, Sahs AL (1981) Early management of aneurysmal subarachnoid haemorrhage. A report of the Cooperative Aneurysm Study. J Neurosurg 54: 141–145

    PubMed  Google Scholar 

  3. Adams HP, Nibbelink DW, Torner JC, Sahs AL (1981) Antifibrinolytic therapy in patients with aneurysmal subarachnoid haemorrhage. A report of the Cooperative Aneurysm Study. Arch Neurol 38: 25–29

    PubMed  Google Scholar 

  4. Alpers BJ, Forster FM (1945) The reparative process in subarachnoid haemorrhage. J Neuropathol Exp Neurol 4: 262–268

    Google Scholar 

  5. Ameen AA, Illinghworth R (1981) Antifibrinolytic treatment in the preoperative management of subarachnoid haemorrhage caused by ruptured intracranial aneurysm. J Neurol Neurosurg Psychiatry 44: 220–226

    PubMed  Google Scholar 

  6. Chandra B (1978) Treatment of subarachnoid haemorrhage from ruptured intracranial aneurysm with tranexamic acid: a double-blind clinical trial. Ann Neurol 3: 502–504

    PubMed  Google Scholar 

  7. Chowdhary UM, Casey PC, Hussein MN (1979) Prevention of early recurrence of spontaneous subarachnoid haemorrhage by e-amino-caproic acid. Lancet II: 741–743

    Google Scholar 

  8. Chowdhary UM, Sayed K (1981) Cooperative clinical trial of epsilon-aminocaproic acid and tranexamic acid in the prevention of early recurrence of subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry 44: 810–813

    PubMed  Google Scholar 

  9. Corkill G (1974) Earlier operation and antifibrinolytic therapy in the management of aneurysmal subarachnoid haemorrhage. Review of recent experience in Tasmania. Med J Australia, pp 468–470

  10. Czernicki Z (1979) Treatment of experimental brain oedema following sudden decompression, surgical wound and cold lesions with vasoprotective drugs and the proteinase inhibitors “Trasylol”. Acta Neurochir (Wien) 50: 311–326

    Google Scholar 

  11. Fisher CH, Kistler JP, Davis JM (1980) Relation of cerebral vasospasm to subarachnoid haemorrhage visualized by computerized tomographic scanning. Neurosurgery 6: 1–9

    PubMed  Google Scholar 

  12. Fodstadt H (1982) Antifibrinolytic treatment in subarachnoid haemorrhage: present state. Acta Neurochir (Wien) 63: 233–244

    Google Scholar 

  13. Fodstadt H, Forssell A, Liliequist B, Schannong M (1981) Antifibrinolysis with tranexamic acid (AMCA) in aneurysmal subarachnoid haemorrhage. A consecutive controlled clinical trial. Neurosurgery 8: 158–165

    PubMed  Google Scholar 

  14. Fodstadt H, Liliequist B, Schannong M, Thulin CA (1978) Tranexamic acid in the preoperative management of ruptured intracranial aneurysms. Surg Neurol 10: 9–15

    PubMed  Google Scholar 

  15. Gelmers HJ (1980) Prevention of recurrence of spontaneous subarachnoid haemorrhage by tranexamic acid. Acta Neurochir (Wien) 52: 45–50

    Google Scholar 

  16. Geronemus R, Herz DA, Schulman H (1974) Streptokinase clot lysis time in patients with ruptured intracranial aneurysms. J Neurosurg 40: 499–503

    PubMed  Google Scholar 

  17. Gibbs JR, Corkill G (1971) Use of antifibrinolytic agents (tranexamic acid) in the management of ruptured intracranial aneurysm. Postgrad Med J 47: 199–200

    PubMed  Google Scholar 

  18. Gibbs JR, O'Gorman P (1967) Fibrinolysis in subarachnoid haemorrhage. Postgrad Med J 43: 779–784

    PubMed  Google Scholar 

  19. Girvin JP (1973) The use of antifibrinolytic agents in the preoperative treatment of ruptured intracranial aneurysms. Trans Amer Neurol Assoc 98: 150–152

    Google Scholar 

  20. Guidetti B, Spallone A (1981) The role of antifibrinolytic therapy in the preoperative management of recently ruptured intracranial aneurysms. Surg Neurol 15: 239–248

    PubMed  Google Scholar 

  21. Ishii M, Suzuki S, Iwabuki T, Julow T (1980) Effect of antifibrinolytic therapy on subarachnoid fibrosis in dogs after experimental subarachnoid haemorrhage. Acta Neurochir (Wien) 54: 17–24

    Google Scholar 

  22. Kägström E, Palma L (1972) Influence of antifibrinolytic treatment on the morbidity in patients with subarachnoid haemorrhage. Acta Neurol Scand 48: 257–258 (abstr)

    Google Scholar 

  23. Kassell NF, Torner JC, Adams HP (1984) Antifibrinolytic agents in the acute period following subarachnoid haemorrhage: preliminary observations from the Cooperative Aneurysm Study. J Neurosurg 61: 225–230

    PubMed  Google Scholar 

  24. Kaste M, Ramsey M (1979) Tranexamic acid in subarachnoid haemorrhage. A double-blind study. Stroke 10: 519–522

    PubMed  Google Scholar 

  25. Kistler JP, Crowell RM, Davis KR, Heros R, Ojemann RG, Fisher CM (1983) The relation of cerebral vasospasm to the extent and location of subarachnoid blood visualized by CT scan: a prospective study. Neurology (NY) 33: 424–436

    Google Scholar 

  26. Knibestöl M, Karadayi A, Tovi D (1976) Echo-encephalographic study of ventricular dilatation after subarachnoid haemorrhage, with special reference to the effect of antifibrinolytic treatment. Acta Neurol Scand 45: 57–70

    Google Scholar 

  27. Locksley HB (1966) Report of the cooperative study of intracranial aneurysms and subarachnoid haemorrhage: Section V. Part II. Natural history of subarachnoid haemorrhage, intracranial aneurysms and arteriovenous malformations: based on 6,368 cases in the Cooperative Study. J Neurosurg 25: 321–368

    PubMed  Google Scholar 

  28. Maurice-Williams RS (1978) Prolonged antifibrinolysis: an effective non surgical treatment for ruptured intracranial aneurysms. Br Med J 1: 945–947

    PubMed  Google Scholar 

  29. Mizukami H, Takemae T, Tazawa T, Kawase T, Matsuzaki T (1980) Value of computed tomography in the prediction of cerebral vasospasm after aneurysmal rupture. Neurosurgery 7: 583–586

    PubMed  Google Scholar 

  30. Mullan S (1975) Conservative management of the recently ruptured aneurysm. Surg Neurol 3: 27–32

    PubMed  Google Scholar 

  31. Mullan S, Dawley J (1968) Antifibrinolytic therapy for intracranial aneurysms. J Neurosurg 28: 21–23

    PubMed  Google Scholar 

  32. Nibbelink DW, Torner JC, Henderson WG (1975) Intracranial aneurysms and subarachnoid haemorrhage. A cooperative study. Antifibrinolytic therapy in recent onset subarachnoid haemorrhage. Stroke 6: 622–629

    PubMed  Google Scholar 

  33. Norlen G, Thulin CA (1969) The use of antifibrinolytic substances in ruptured intracranial aneurysms. Neurochirurgia 12: 100–102

    PubMed  Google Scholar 

  34. Park BE (1979) Spontaneous subarachnoid haemorrhage complicated by communicating hydrocephalus: epsilon-aminocaproic acid as a possible predisposing factor. Surg Neurol 11: 73–80

    PubMed  Google Scholar 

  35. Pasqualin A, Rosta L, Da Pian R, Cavazzani P, Scienza R (1984) Role of computed tomography in the management of vasospasm after subarachnoid haemorrhage. Neurosurgery 15: 344–353

    PubMed  Google Scholar 

  36. Post KD, Flamm ES, Goodgold A, Ransohoff J (1977) Ruptured intracranial aneurysms. Case morbidity and mortality. J Neurosurg 46: 290–295

    PubMed  Google Scholar 

  37. Profeta G, Castellano F, Guarnieri L, Cigliano A, Ambrosio A (1975) Antifibrinolytic therapy in the treatment of subarachnoid haemorrhage caused by arterial aneurysms. J Neurosurg Sci 19: 77–78

    PubMed  Google Scholar 

  38. Ramirez-Lassepas M (1981) Antifibrinolytic therapy in subarachnoid haemorrhage caused by ruptured intracranial aneurysm. Neurology (NY) 31: 316–322

    Google Scholar 

  39. Ransohoff J, Goodgold A, Benjamin MW (1972) Preoperative management of patients with ruptured intracranial aneurysms. J Neurosurg 36: 525–530

    PubMed  Google Scholar 

  40. Schisano G (1978) The use of antifibrinolytic drugs in aneurysmal subarachnoid haemorrhage. Surg Neurol 10: 217–222

    PubMed  Google Scholar 

  41. Sengupta SC, So SC, Villarejo-Ortega FJ (1976) Use of epsilonaminocaproic acid (EACA) in the preoperative management of ruptured intracranial aneurysms. J Neurosurg 44: 476–484

    Google Scholar 

  42. Shaw MDM, Miller JD (1974) Epsilon aminocaproic acid and recurrent subarachnoid haemorrhage. Lancet II: 847–848

    Google Scholar 

  43. Shucart WA, Hussain SK, Cooper PR (1980) Epsilon aminocaproic acid and recurrent subarachnoid haemorrhage. A clinical trial. J Neurosurg 53: 28–31

    PubMed  Google Scholar 

  44. Sicuteri F (1974) Treatment of subarachnoid and other intracranial haemorrhages with proteinase inhibitor. Ann NY Acad Sci 146: 682–700

    Google Scholar 

  45. Sonntag VKM, Stein BM (1974) Arteriopatic complications during treatment of subarachnoid haemorrhage with epsilon-aminocaproic acid. J Neurosurg 40: 480–485

    PubMed  Google Scholar 

  46. Spallone A (1982) Antifibrinolysis in aneurysmal subarachnoid haemorrhage. A retrospective comparison of two different forms of antifibrinolytic therapy. Acta Neurochir (Wien) 63: 254–250

    Google Scholar 

  47. Suzuki J, Komatsu S, Sato T, Sakurai Y (1980) Correlation between CT findings and subsequent development of cerebral infarction due to vasospasm in subarachnoid haemorrhage. Acta Neurochir (Wien) 55: 63–70

    Google Scholar 

  48. Suzuki S, Ishii M, Ottomo M, Iwabuchi T (1977) Changes in the subarachnoid space after experimental subarachnoid haemorrhage in the dog: scanning electron microscopic observations. Acta Neurochir (Wien) 39: 1–14

    Google Scholar 

  49. Torner JC, Kassell NF, Wallace RB, Adams HP (1981) Preoperative prognostic factors for rebleeding and survival in aneurysm patients receiving antifibrinolytic therapy: report of the cooperative aneurysm study. Neurosurgery 9: 506–513

    PubMed  Google Scholar 

  50. Tovi D (1973) The use of antifibrinolytic drugs to prevent early recurrent aneurysmal subarachnoid haemorrhage. Acta Neurol Scand 49: 163–179

    PubMed  Google Scholar 

  51. Tovi D, Nilsson IM, Thulin CA (1972) Fibrinolysis and subarachnoid haemorrhage. Inhibitory effect of tranexamic acid. A clinical study. Acta Neurol Scand 48: 393–402

    PubMed  Google Scholar 

  52. Tovi D, Thulin CA (1972) Ability of tranexamic acid to cross the blood-brain barrier and its use in patients with ruptured intracranial aneurysms. Acta Neurol Scand 48: 257 (abstr)

    Google Scholar 

  53. Uttley D, Richardson AE (1974) E-aminocaproic acid and subarachnoid haemorrhage. Lancet II: 1080–1081

    Google Scholar 

  54. Van Rossum J, Wintzen AR, Endtz LJ, Shoen JHR, Jonge H (1977) Effect of tranexamic acid on rebleeding after subarachnoid haemorrhage: a double-blind controlled clinical trial. Ann Neurol 2: 238–242

    Google Scholar 

  55. Vassilouthis J, Richardson AE (1979) Ventricular dilatation and communicating hydrocephalus following spontaneous subarachnoid haemorrhage. J Neurosurg 51: 341–351

    PubMed  Google Scholar 

  56. Vermeulen M, Lindsay KW, Murray GD, Cheah F, Hijdra A, Muizelaar JP, Schannong M, Teasdale GM, Van Crevel H, Van Gijin J (1984) Antifibrinolytic treatment in subarachnoid haemorrhage. N Engl J Med 311: 43–437

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurosurgery, Verona City Hospital, Verona, Italy

    G. Pinna, A. Pasqualin, C. Vivenza & R. Da Pian

Authors
  1. G. Pinna
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Pasqualin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. Vivenza
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. R. Da Pian
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pinna, G., Pasqualin, A., Vivenza, C. et al. Rebleeding, ischaemia and hydrocephalus following anti-fibrinolytic treatment for ruptured cerebral aneurysms: A retrospective clinical study. Acta neurochir 93, 77–87 (1988). https://doi.org/10.1007/BF01402885

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01402885

Keywords

Search

Navigation